Skip to main navigation
Skip to search
Skip to main content
Manipal Academy of Higher Education, Manipal, India Home
Help & FAQ
Home
Profiles
Research Units
Research output
Equipment
Search by expertise, name or affiliation
Sacubitril/valsartan: A new paradigm in heart failure
Sunil Pai,
Priyanka Kamath
Department of Pharmacology, Kasturba Medical College, Mangalore
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Sacubitril/valsartan: A new paradigm in heart failure'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Sacubitril
100%
Valsartan
76%
Angiotensin
63%
Receptor Blocking Agent
54%
Drug
26%
Digoxin
23%
Angiotensin-Converting Enzyme Inhibitor
23%
Diuretic
22%
Peptide Hydrolase Inhibitor
21%
Block Like Crystal
11%
Molecule
5%
Medicine & Life Sciences
LCZ 696
81%
Heart Failure
36%
Neprilysin
26%
Angiotensin Receptor Antagonists
22%
Valsartan
13%
Angioedema
13%
Pharmaceutical Preparations
12%
Angiotensin Receptors
12%
Digoxin
11%
Vascular Stiffness
11%
Diuretics
10%
United States Food and Drug Administration
9%
Angiotensin-Converting Enzyme Inhibitors
9%
Hypotension
9%
Chronic Renal Insufficiency
9%
Dyspnea
8%
Fatigue
8%
Hospitalization
7%
Clinical Trials
6%
Exercise
6%
Therapeutics
1%